PE11399A1 - Combinacion de loratadina y un descongestionante para el tratamiento del asma - Google Patents

Combinacion de loratadina y un descongestionante para el tratamiento del asma

Info

Publication number: PE11399A1
Authority: PE; Peru
Prior art keywords: patient; asthma; loratadine; combination; treatment
Prior art date: 1996-10-31

Application number

PE1997000968A

Other languages

English (en)

Spanish (es)

Inventor

Alan G Harris

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-31

Filing date

1997-10-29

Publication date

1999-02-09

1997-10-29 Application filed by Schering Corp filed Critical Schering Corp

1999-02-09 Publication of PE11399A1 publication Critical patent/PE11399A1/es

Links

208000006673 asthma Diseases 0.000 title abstract 4
JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 title abstract 2
229960003088 loratadine Drugs 0.000 title abstract 2
KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
239000000739 antihistaminic agent Substances 0.000 abstract 2
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
230000001387 anti-histamine Effects 0.000 abstract 1
229940125715 antihistaminic agent Drugs 0.000 abstract 1
230000009286 beneficial effect Effects 0.000 abstract 1
KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
230000002249 decongestive effect Effects 0.000 abstract 1
DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 abstract 1
229960002179 ephedrine Drugs 0.000 abstract 1
230000002650 habitual effect Effects 0.000 abstract 1
230000004199 lung function Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229940126601 medicinal product Drugs 0.000 abstract 1
229960001802 phenylephrine Drugs 0.000 abstract 1
SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 abstract 1
DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical group C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 abstract 1
229960000395 phenylpropanolamine Drugs 0.000 abstract 1
206010039083 rhinitis Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PE1997000968A 1996-10-31 1997-10-29 Combinacion de loratadina y un descongestionante para el tratamiento del asma PE11399A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US73966996A	1996-10-31	1996-10-31

Publications (1)

Publication Number	Publication Date
PE11399A1 true PE11399A1 (es)	1999-02-09

Family

ID=24973307

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PE1997000968A PE11399A1 (es)	1996-10-31	1997-10-29	Combinacion de loratadina y un descongestionante para el tratamiento del asma

Country Status (21)

Country	Link
EP (1)	EP0941091A1 (ja)
JP (1)	JP2000505104A (ja)
KR (1)	KR20000052922A (ja)
CN (1)	CN1235545A (ja)
AR (1)	AR008908A1 (ja)
AU (1)	AU731756B2 (ja)
BR (1)	BR9712705A (ja)
CA (1)	CA2268546A1 (ja)
CO (1)	CO4910128A1 (ja)
CZ (1)	CZ150999A3 (ja)
HU (1)	HUP9904075A3 (ja)
ID (1)	ID23431A (ja)
IL (1)	IL129662A0 (ja)
NO (1)	NO992062D0 (ja)
NZ (1)	NZ335078A (ja)
PE (1)	PE11399A1 (ja)
PL (1)	PL333056A1 (ja)
SK (1)	SK54599A3 (ja)
TR (1)	TR199901003T2 (ja)
WO (1)	WO1998018470A1 (ja)
ZA (1)	ZA979731B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6270796B1 (en) *	1997-10-29	2001-08-07	Robert E. Weinstein	Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) *	1998-06-01	2000-10-17	Schering Corporation	Stabilized antihistamine syrup
IT1303671B1 (it) *	1998-07-28	2001-02-23	Nicox Sa	Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
AU6018899A (en) *	1998-09-10	2000-04-03	Schering Corporation	Antihistamines for treating non-infective sinusitis or otitis media
US6521254B2 (en)	1998-12-07	2003-02-18	J-Med Pharmaceuticals, Inc.	Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) *	1999-02-23	2005-08-01	주식회사유한양행	로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
ATE253354T1 (de) *	1999-02-23	2003-11-15	Yuhan Corp	Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
WO2000057880A1 (en) *	1999-03-29	2000-10-05	Schering Corporation	Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045668A2 (en) *	1999-12-20	2001-06-28	Schering Corporation	Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
WO2001045676A2 (en) *	1999-12-20	2001-06-28	Schering Corporation	Extended release oral dosage composition
JP5592042B2 (ja) *	2000-04-14	2014-09-17	ジェイ−メドファーマシューティカルズ，インコーポレーティッド	鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
PE20020055A1 (es) *	2000-05-25	2002-02-12	Schering Corp	Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
WO2003000264A1 (en) *	2001-06-20	2003-01-03	Schering Corporation	Antihistamines for the treatment of nasal congestion and nasal obstruction
RU2423979C2 (ru) *	2005-06-17	2011-07-20	АФТ Фармасьютикалз Лимитед	Новая фармацевтическая композиция и ее применение в способе лечения пациентов с гиперемией и отеком слизистой оболочки верхних дыхательных путей
AU2005333081B2 (en)	2005-06-17	2010-06-24	Aft Pharmaceuticals Limited	Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
NZ573174A (en) *	2006-06-01	2012-01-12	Msd Consumer Care Inc	Sustained release pharmaceutical dosage form containing phenylephrine
CN104161736A (zh) *	2006-06-01	2014-11-26	Msd消费保健品公司	包含去氧肾上腺素的缓释药物制剂
KR101540191B1 (ko) *	2014-02-24	2015-07-28	성균관대학교산학협력단	로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1110397A (en) *	1964-10-02	1968-04-18	Mead Johnson & Co	Ephedrine composition
US4990535A (en) *	1989-05-03	1991-02-05	Schering Corporation	Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) *	1991-11-27	1995-04-18	Sidmak Laboratories, Inc.	Sustained release composition for oral administration of active ingredient
US5314697A (en) *	1992-10-23	1994-05-24	Schering Corporation	Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) *	1994-12-30	1997-01-21	Sepracor Inc.	Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

1997
- 1997-10-29 EP EP97912874A patent/EP0941091A1/en not_active Withdrawn
- 1997-10-29 SK SK545-99A patent/SK54599A3/sk unknown
- 1997-10-29 CN CN97199404A patent/CN1235545A/zh active Pending
- 1997-10-29 AU AU49953/97A patent/AU731756B2/en not_active Ceased
- 1997-10-29 BR BR9712705-1A patent/BR9712705A/pt not_active Application Discontinuation
- 1997-10-29 WO PCT/US1997/019158 patent/WO1998018470A1/en not_active Ceased
- 1997-10-29 TR TR1999/01003T patent/TR199901003T2/xx unknown
- 1997-10-29 CA CA002268546A patent/CA2268546A1/en not_active Abandoned
- 1997-10-29 NZ NZ335078A patent/NZ335078A/xx unknown
- 1997-10-29 ID IDW990280D patent/ID23431A/id unknown
- 1997-10-29 HU HU9904075A patent/HUP9904075A3/hu unknown
- 1997-10-29 KR KR1019990703790A patent/KR20000052922A/ko not_active Ceased
- 1997-10-29 PL PL97333056A patent/PL333056A1/xx unknown
- 1997-10-29 ZA ZA9709731A patent/ZA979731B/xx unknown
- 1997-10-29 IL IL12966297A patent/IL129662A0/xx unknown
- 1997-10-29 PE PE1997000968A patent/PE11399A1/es not_active Application Discontinuation
- 1997-10-29 JP JP10520579A patent/JP2000505104A/ja active Pending
- 1997-10-29 CZ CZ991509A patent/CZ150999A3/cs unknown
- 1997-10-29 CO CO97063641A patent/CO4910128A1/es unknown
- 1997-10-29 AR ARP970105033A patent/AR008908A1/es not_active Application Discontinuation
1999
- 1999-04-29 NO NO992062A patent/NO992062D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN1235545A (zh)	1999-11-17
WO1998018470A1 (en)	1998-05-07
JP2000505104A (ja)	2000-04-25
CA2268546A1 (en)	1998-05-07
BR9712705A (pt)	1999-10-26
SK54599A3 (en)	2000-08-14
AR008908A1 (es)	2000-02-23
HUP9904075A3 (en)	2002-02-28
KR20000052922A (ko)	2000-08-25
CZ150999A3 (cs)	1999-10-13
AU4995397A (en)	1998-05-22
PL333056A1 (en)	1999-11-08
IL129662A0 (en)	2000-02-29
ID23431A (id)	2000-04-20
NO992062L (no)	1999-04-29
CO4910128A1 (es)	2000-04-24
EP0941091A1 (en)	1999-09-15
TR199901003T2 (xx)	1999-07-21
NO992062D0 (no)	1999-04-29
HUP9904075A2 (hu)	2000-05-28
ZA979731B (en)	1998-04-29
NZ335078A (en)	2000-10-27
AU731756B2 (en)	2001-04-05

Similar Documents

Publication	Publication Date	Title
DE69721766D1 (de)	2003-06-12	Neue arzneiformulierung
DE69400435D1 (de)	1996-10-02	Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
YU59092A (sh)	1994-12-28	Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
BR0008276A (pt)	2001-11-06	Combinações de formoterol e propionato de fluticasona para asma
BRPI0108435B8 (pt)	2021-05-25	formulação e uso de entecavir de baixa dose
NO20042596L (no)	2004-06-21	Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
ATE329608T1 (de)	2006-07-15	Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
AR016798A1 (es)	2001-08-01	Uso de una cepa de lactobacillus para la elaboracion de un medicamento
ES2166111T3 (es)	2002-04-01	Uso de tiagabina para el tratamiento de trastornos del sueño.
NO990522L (no)	1999-03-30	Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer
AR008908A1 (es)	2000-02-23	Uso de loratadina y un descongestivo para preparar un medicamento para mejorar la funcion pulmonar de un paciente que padece asma
NO20004419D0 (no)	2000-09-05	Ny anvendelse
ATE291914T1 (de)	2005-04-15	Zolmitriptanhaltige arzneizusammensetzungen
DE60002885D1 (de)	2003-06-26	Wässrige formulierung zur nasalen verabreichung
DE60214527D1 (de)	2006-10-19	Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit
AR023687A1 (es)	2002-09-04	Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
EE9700366A (et)	1998-06-15	Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
NO20013414L (no)	2001-07-10	Ny anvendelse av melagatran
ATE271852T1 (de)	2004-08-15	Verbesserte inhalationspräparate
TR199901385T2 (xx)	1999-11-22	Piperidin t�revleri.
NO20032006D0 (no)	2003-05-05	Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
BG105984A (bg)	2002-04-30	Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
HUP9701606A2 (hu)	1998-06-29	Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására
BR0206918A (pt)	2004-02-03	Uso de iloperidona
ATE291904T1 (de)	2005-04-15	2,4-dichlorbenzylalkohol und amylmetakresol gegen hiv-infektion

Legal Events

Date	Code	Title	Description
2002-04-29	FC	Refusal